BIO-key Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time

MADRID, Spain and HOLMDEL, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions has successfully completed the deployment of a comprehensive suite of BIO-key biometric-based IAM solutions for a new International Defense Agency customer. The full deployment for the initial sites was completed in just four days, showcasing the efficiency, seamless integration, and collaboration between BIO-key and the customer’s IT team.

The deployment incorporates these BIO-key solutions:

• PortalGuard On-Prem – A highly secure IAM platform providing Multi-factor Authentication (MFA) and Single Sign-On (SSO) capabilities.
• WEB-key – Advanced biometric authentication enabling secure and seamless access to critical systems.
• BIO-key PIV-Pro and ECO2 Fingerprint Scanners – FIPS-certified biometric scanning devices ensuring high-security access control.
• Passkey:YOU FIDO2 Authentication – Enabling passwordless, phishing-resistant authentication for compliance with modern security standards.

The implementation demonstrates BIO-key’s expertise in delivering high-security, passwordless and phoneless authentication solutions for critical environments.

Alex Rocha, International Managing Director at BIO-key, commented, "This project is a testament to the power of innovative thinking, cutting-edge technology and strong partnerships to forge highly secure and efficient passwordless and phoneless access management. Despite the complexity of the solution, our teams worked together seamlessly to complete the deployment in record time. The customer now benefits from a highly secure, scalable authentication system that enhances security while simplifying access. We look forward working with the customer on the planned expansion of this deployment in the coming months."

Nelson Junior, Technical Manager at BIO-key International, added "Completing a project of this scale in just four days is a major accomplishment. It underscores the seamless integration capabilities of BIO-key’s IAM solutions and the dedication of our team. The success of this deployment reflects our ability to provide fast, secure, and scalable authentication solutions that meet the highest security standards."

About BIO-key International, Inc. ()

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements, whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Investor Contacts

William Jones, David Collins

Catalyst IR

212-924-9800